Rapid Purification of Endotoxin-Free RTX Toxins.


Journal

Toxins
ISSN: 2072-6651
Titre abrégé: Toxins (Basel)
Pays: Switzerland
ID NLM: 101530765

Informations de publication

Date de publication:
12 06 2019
Historique:
received: 14 05 2019
revised: 05 06 2019
accepted: 07 06 2019
entrez: 20 6 2019
pubmed: 20 6 2019
medline: 17 3 2020
Statut: epublish

Résumé

Cytolytic leukotoxins of the repeat in toxin (RTX) family are large proteins excreted by gram-negative bacterial pathogens through the type 1 secretion system (T1SS). Due to low yields and poor stability in cultures of the original pathogens, it is useful to purify recombinant fatty-acylated RTX cytolysins from inclusion bodies produced in

Identifiants

pubmed: 31212877
pii: toxins11060336
doi: 10.3390/toxins11060336
pmc: PMC6628407
pii:
doi:

Substances chimiques

Bacterial Proteins 0
Cytotoxins 0
Detergents 0
Hemolysin Proteins 0
Lipopolysaccharides 0
Urea 8W8T17847W
Octoxynol 9002-93-1
Nonidet P-40 9036-19-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

J Biol Chem. 1988 Feb 25;263(6):2612-8
pubmed: 2893792
Sci Rep. 2016 Sep 01;6:29137
pubmed: 27581058
Infect Immun. 1996 Nov;64(11):4415-23
pubmed: 8890186
J Immunol. 2008 Oct 15;181(8):5587-97
pubmed: 18832717
Elife. 2015 Dec 09;4:e10766
pubmed: 26650353
Infect Immun. 1990 Oct;58(10):3445-7
pubmed: 2401570
J Exp Med. 2001 May 7;193(9):1035-44
pubmed: 11342588
Microb Cell Fact. 2011 Jul 26;10:57
pubmed: 21787435
Biochem Biophys Res Commun. 2018 Jan 15;495(3):2118-2124
pubmed: 29253571
Vaccine. 2007 Jan 2;25(1):64-71
pubmed: 16916566
Immunol Lett. 2006 Jul 15;106(1):1-7
pubmed: 16765451
Hum Vaccin. 2005 Jul-Aug;1(4):151-9
pubmed: 17012877
Proc Natl Acad Sci U S A. 1998 May 12;95(10):5752-6
pubmed: 9576956
Emerg Microbes Infect. 2018 Nov 7;7(1):178
pubmed: 30405113
Infect Immun. 2000 Jan;68(1):247-56
pubmed: 10603395
Int J Med Microbiol. 2016 Jan;306(1):38-47
pubmed: 26699834
Biologicals. 2012 Jul;40(4):309-11
pubmed: 22609106
Nature. 2009 Apr 30;458(7242):1191-5
pubmed: 19252480
J Leukoc Biol. 2004 Sep;76(3):514-9
pubmed: 15178705
Infect Immun. 1990 Oct;58(10):3242-7
pubmed: 2401563
J Biol Chem. 2003 Jun 20;278(25):22523-9
pubmed: 12686536
Microb Pathog. 1992 Mar;12(3):227-35
pubmed: 1614333
Cell Signal. 2001 Feb;13(2):85-94
pubmed: 11257452
J Bacteriol. 2007 Jan;189(2):430-6
pubmed: 17098895
J Virol. 2005 Aug;79(15):9872-84
pubmed: 16014948
Protein Expr Purif. 2006 Apr;46(2):483-8
pubmed: 16290005
Protein Expr Purif. 2000 Feb;18(1):95-9
pubmed: 10648174
J Pharm Pharm Sci. 2007;10(3):388-404
pubmed: 17727802
FEMS Microbiol Rev. 2010 Nov;34(6):1076-112
pubmed: 20528947
J Immunol Methods. 1990 Sep 14;132(2):191-5
pubmed: 2170533
Infect Immun. 2013 Dec;81(12):4571-82
pubmed: 24082076
Arch Otorhinolaryngol. 1979;225(4):269-77
pubmed: 548013
Clin Biochem. 1997 Aug;30(6):455-63
pubmed: 9316739
Mol Cell. 2016 Apr 7;62(1):47-62
pubmed: 27058787
Toxins (Basel). 2017 Sep 24;9(10):
pubmed: 28946636
Biochim Biophys Acta. 2016 Mar;1858(3):538-45
pubmed: 26299820
J Immunol. 2010 Aug 1;185(3):1711-9
pubmed: 20610650

Auteurs

Ondrej Stanek (O)

Institute of Microbiology of the CAS, Videnska 1083, 142 20 Prague, Czech Republic. stanek@biomed.cas.cz.

Jiri Masin (J)

Institute of Microbiology of the CAS, Videnska 1083, 142 20 Prague, Czech Republic. masin@biomed.cas.cz.

Radim Osicka (R)

Institute of Microbiology of the CAS, Videnska 1083, 142 20 Prague, Czech Republic. osicka@biomed.cas.cz.

David Jurnecka (D)

Institute of Microbiology of the CAS, Videnska 1083, 142 20 Prague, Czech Republic. david.jurnecka@biomed.cas.cz.
Faculty of Science, Charles University, Hlavova 2030, 128 43 Prague, Czech Republic. david.jurnecka@biomed.cas.cz.

Adriana Osickova (A)

Institute of Microbiology of the CAS, Videnska 1083, 142 20 Prague, Czech Republic. osickova@biomed.cas.cz.
Faculty of Science, Charles University, Hlavova 2030, 128 43 Prague, Czech Republic. osickova@biomed.cas.cz.

Peter Sebo (P)

Institute of Microbiology of the CAS, Videnska 1083, 142 20 Prague, Czech Republic. sebo@biomed.cas.cz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH